Wall Street analysts predict that Keurig Dr Pepper Inc (NYSE:KDP) will report earnings per share (EPS) of $0.31 for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Keurig Dr Pepper’s earnings. The highest EPS estimate is $0.32 and the lowest is $0.29. Keurig Dr Pepper posted earnings of $1.17 per share during the same quarter last year, which suggests a negative year over year growth rate of 73.5%. The company is expected to announce its next quarterly earnings results on Wednesday, February 13th.
On average, analysts expect that Keurig Dr Pepper will report full-year earnings of $1.04 per share for the current financial year, with EPS estimates ranging from $1.00 to $1.07. For the next financial year, analysts forecast that the business will post earnings of $1.24 per share, with EPS estimates ranging from $1.19 to $1.26. Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that follow Keurig Dr Pepper.
Keurig Dr Pepper (NYSE:KDP) last posted its earnings results on Wednesday, November 7th. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.02. The firm had revenue of $2.73 billion during the quarter, compared to the consensus estimate of $2.87 billion. Keurig Dr Pepper had a return on equity of 46.22% and a net margin of 13.55%. The company’s quarterly revenue was up 139.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.21 EPS.
A number of research analysts have recently commented on the company. ValuEngine downgraded Keurig Dr Pepper from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 2nd. Guggenheim assumed coverage on Keurig Dr Pepper in a research report on Thursday, September 13th. They set a “neutral” rating and a $22.00 target price for the company. Zacks Investment Research upgraded Keurig Dr Pepper from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Citigroup increased their target price on Keurig Dr Pepper from $15.46 to $26.00 and gave the company a “neutral” rating in a research report on Friday, August 10th. Finally, Susquehanna Bancshares assumed coverage on Keurig Dr Pepper in a research report on Wednesday, July 25th. They set a “positive” rating and a $33.00 target price for the company. Nine research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $25.38.
Shares of NYSE KDP traded up $0.05 during midday trading on Monday, reaching $28.52. 1,954,139 shares of the stock traded hands, compared to its average volume of 3,572,976. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.75 and a current ratio of 0.93. The company has a market capitalization of $38.37 billion, a P/E ratio of 6.28, a P/E/G ratio of 1.65 and a beta of 0.47. Keurig Dr Pepper has a one year low of $20.46 and a one year high of $126.65.
The business also recently declared a quarterly dividend, which was paid on Friday, October 19th. Investors of record on Friday, October 5th were given a $0.15 dividend. The ex-dividend date was Thursday, October 4th. This represents a $0.60 dividend on an annualized basis and a yield of 2.10%. Keurig Dr Pepper’s dividend payout ratio is presently 13.22%.
In related news, insider Brian Andrew Loucks purchased 13,050 shares of the stock in a transaction that occurred on Thursday, September 6th. The stock was bought at an average cost of $22.86 per share, for a total transaction of $298,323.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Maria A. Sceppaguercio-Gever purchased 49,638 shares of the stock in a transaction that occurred on Thursday, September 13th. The stock was bought at an average price of $23.91 per share, with a total value of $1,186,844.58. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 188,320 shares of company stock valued at $4,399,673. 0.58% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Canada Pension Plan Investment Board bought a new stake in Keurig Dr Pepper in the third quarter worth $2,054,000. Trexquant Investment LP bought a new stake in Keurig Dr Pepper in the third quarter worth $1,549,000. DekaBank Deutsche Girozentrale bought a new stake in Keurig Dr Pepper in the third quarter worth $1,202,000. Ontario Teachers Pension Plan Board bought a new stake in Keurig Dr Pepper in the third quarter worth $278,000. Finally, FMR LLC bought a new stake in Keurig Dr Pepper in the third quarter worth $459,135,000. Institutional investors own 11.56% of the company’s stock.
About Keurig Dr Pepper
Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.
Read More: Penny Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.